The combination of low-dose tPA with rA2 also improved long-term neurologic function one month after the induction of a stroke [42] and reduced early blood–brain barrier disruption in the rat embolic stroke model [43] without significant hemorrhagic transformation. The gene discussed is PLAT; the disease is stroke disorder.